Therapeutic Particularities with Depot Medications in Schizophrenia

Curr Health Sci J. 2018 Jul-Sep;44(3):322-325. doi: 10.12865/CHSJ.44.03.19. Epub 2018 Jul 15.

Abstract

Schizophrenia is a neurodegenerative disease with personality degradation, changes in behavior, cognition, affective disorder and reduced socio-professional insertion. Early diagnosis is necessary and maintenance is ensured by antipsychotic treatment and for non-compliant patients there is an alternative to depot medication that greatly improves therapeutic adherence. The study presents the case of a 43-year-old patient diagnosed with paranoid schizophrenia using the Diagnostic and Statistical Manual of Mental Disorders V-TR criteria that showed a favorable evolution under depot treatment.

Keywords: Schizophrenia; depot treatment; psychodiagnosis.